-
<![CDATA[Ozempic Shows Greater Effect in Reducing Stroke, Heart Attack Risk Over Competitor Dulaglutide]]>
24 Sep 2025 00:13 GMT
… , findings showed that semaglutide (Ozempic; Novo Nordisk), an FDA-approved glucagon-like … and diabetes, outperformed dulaglutide, a competitor GLP-1 RA, in lowering … and cardiovascular disease. News release. Novo Nordisk. August 31, 2025. Accessed September …
-
If you build it, tariffs won’t come: Pharma’s billion-dollar ultimatum
26 Sep 2025 22:19 GMT
… of these projects appears fortuitous. Novo Nordisk, despite announcing a $4.1 … biologics (broke ground March 2025)
Novo Nordisk: $4.1B Clayton NC (site … may find themselves disadvantaged against competitors who happened to time their …
-
Eli Lilly terminates trial of Zepbound and muscle-sparing combo
26 Sep 2025 21:42 GMT
… in combination with Novo Nordisk’s Wegovy (semaglutide) – a staunch competitor of Lilly …
-
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
26 Sep 2025 12:28 GMT
… tariffs increase import costs for competitors.
Vertex Pharmaceuticals (NASDAQ: VRTX … manufacturing investment commitments compared to competitors, leaving them exposed to … expansion announcement provides some protection. Novo Nordisk (NYSE: NVO), despite its …
-
Denmark Town Nicknamed ‘Novo Town’ Braces for Impact from Layoffs
25 Sep 2025 23:27 GMT
… that layoffs impact real people.
Novo Nordisk recently announced plans to streamline … drug.
Since then, however, multiple competitors have released their own GLP … operations and reinvest for growth. Novo Nordisk. September 10, 2025. Accessed September …
-
Global Wearable Medical Devices Market is Predicted to Reach USD 185 Billion by 2032 | DelveInsight
25 Sep 2025 17:00 GMT
… Services, INC., FitBit, Qardio, Inc., Novo Nordisk A/S, Emperra GmbH … Becton, Dickinson and Company, Medtronic, Novo Nordisk A/S, Ypsomed Holding … and actionable intelligence on their competitors and markets of interest to …
-
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
25 Sep 2025 10:39 GMT
… potential rival to heavyweights Novo Nordisk and Eli Lilly as … biotech company 89bio, joining competitors in developing new liver disease … comments, adding that other competitor treatments were likely to … rivals Eli Lilly and Novo Nordisk have been racing to …
-
Pharma lobbyists cash in on Brussels red tape rampage
25 Sep 2025 11:21 GMT
… , Eli Lilly, Johnson & Johnson, Novo Nordisk, Merck and many other pharma … they develop, before cheaper generic competitors can enter the market.
The …
-
Can oral GLP-1RAs deliver on the promise of accessible obesity care?
23 Sep 2025 14:39 GMT
… accessible for patients.
Both Novo Nordisk and Eli Lilly have … .
Find out more
In Novo Nordisk’s OASIS4 trial (NCT05035095), … ahead of regulatory approval.
Novo Nordisk’s oral semaglutide is already … definitely emerge as strong competitors. It really all comes …
-
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
23 Sep 2025 12:30 GMT
… product candidates; new or existing competitors with greater resources and capabilities … ® is a registered trademark of Novo Nordisk A/S. Investor and …
About
© 1995-2025